Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 2 positive fiscal years (FY2023, FY2024). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $19.28 today, the market must believe free cash flow compounds 17.4%/yr for a decade (off $31.5M on the 3-yr avg basis).
On the basis ($13.6M) the requirement is 29.1%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
Default is 10.0% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.03B shares (market data) · net debt $678.4M
mean -41.0% · volatility σ 101% · implied rate exceeded in 2/8 yrs
Central path = implied 17.4%/yr growth; shaded band = ±1σ (101%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 26 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLW | $111.0B | 70.4× | 31.4× | 7.1× | 19.1% | 36.0% | 10.2% | 13.5% | 12.7% | -0.2× | 829 |
| HWM | $82.1B | 55.5× | 36.3× | 9.9× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.0× | 458 |
| NUE | $62.5B | 36.6× | — | 1.9× | 5.7% | 11.9% | 5.4% | 8.3% | 8.3% | — | 501 |
| STLD | $36.1B | 31.7× | 19.5× | 2.0× | 3.6% | 13.2% | 6.5% | 13.2% | 9.0% | 1.7× | 298 |
| ATI | $23.8B | 61.4× | 29.0× | 5.2× | 5.2% | 22.0% | 8.8% | 22.4% | 22.0% | -0.5× | 218 |
| CRS | $14.8B | 28.4× | 17.8× | 4.7× | 8.6% | 30.6% | 17.0% | 23.8% | 18.2% | 0.3× | 195 |
| MLI | $12.2B | 8.1× | 10.5× | 2.9× | 10.9% | — | 18.3% | 23.8% | 23.8% | -1.3× | 194 |
| AA | $10.5B | 9.1× | 18.1× | 0.8× | 7.9% | — | 9.0% | 18.9% | 13.5% | 1.4× | 134 |
| CMC | $7.2B | 11.2× | — | 0.8× | 20.5% | 18.6% | 7.0% | 14.0% | 8.2% | — | 120 |
| BDC | $4.2B | 18.2× | 11.4× | 1.6× | 10.3% | 38.0% | 8.7% | 18.8% | 9.3% | 2.0× | 64 |
| CENX | $3.4B | 82.5× | 15.4× | 1.4× | 13.9% | 10.1% | 1.7% | 5.2% | 3.1% | 1.7× | 66 |
| CSTM | $3.2B | 12.5× | — | 0.4× | 15.2% | — | 3.2% | 28.7% | 9.4% | — | 53 |
| WOR | $3.2B | 20.5× | 29.9× | 2.3× | 19.7% | 27.4% | 11.3% | 15.2% | 11.7% | 2.4× | 73 |
| WS | $2.2B | 247.6× | 32.1× | 0.6× | 11.3% | 11.7% | 0.2% | 0.8% | 0.7% | 2.0× | 52 |
| KALU | $2.0B | 17.7× | 9.7× | 0.6× | 11.5% | 13.1% | 3.3% | 13.6% | 6.0% | 3.4× | 57 |
| ROCK | $1.2B | — | 7.1× | 1.1× | 11.0% | 26.9% | -3.9% | -4.7% | -4.7% | -0.8× | 46 |
| NX | $951M | — | — | 0.5× | 43.8% | 27.2% | -13.6% | -34.5% | -17.7% | — | 37 |
| NWPX | $944M | 27.5× | — | 1.8× | 6.8% | 19.7% | 6.7% | 9.0% | 8.7% | — | 33 |
| SXC | $936M | — | 14.0× | 0.5× | -5.1% | — | -2.4% | -7.4% | -3.4% | 5.5× | 38 |
| MTUS | $888M | — | 12.7× | 0.8× | 6.9% | 8.2% | -0.1% | -0.2% | -0.2% | -2.7× | 43 |
| MATW | $604M | — | 8.7× | 0.4× | -16.6% | 33.9% | -1.6% | -5.1% | -2.1% | 4.6× | 24 |
| IIIN | $561M | 13.8× | 7.2× | 0.9× | 22.4% | 14.4% | 6.3% | 11.0% | 11.0% | -0.5× | 36 |
| UAMY | $468M | — | — | 11.9× | 163% | 25.2% | -11.1% | -3.1% | -3.1% | — | 50 |
| TWI | $317M | — | 8.2× | 0.2× | -0.9% | 13.9% | -3.5% | -12.3% | -5.7% | 4.6× | 27 |
| FRD | $311M | 49.6× | 48.6× | 0.7× | -13.9% | 0.6% | 1.4% | 4.6% | 4.6% | -0.6× | 11 |
Peers = companies sharing MATW's sector (Nonferrous Foundries (Castings)) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 26 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $32.8M dividends + $12.2M buybacks = $45.0M returned on -$59.4M FCF.
9 consecutive years of dividend increases · 7%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -2%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.50B 100.0% | $1.80B 100.0% | $1.88B 100.0% | $1.76B 100.0% | $1.67B 100.0% | $1.50B 100.0% | $1.54B 100.0% | $1.60B 100.0% | $1.52B 100.0% | $1.48B 100.0% |
| Cost of Revenue | $990.1M 66.1% | $1.27B 70.5% | $1.30B 69.3% | $1.24B 70.4% | $1.13B 67.6% | $1.00B 66.8% | $994.8M 64.7% | $1.02B 63.5% | $947.8M 62.5% | $924.0M 62.4% |
| Gross Profit | $507.6M 33.9% | $529.7M 29.5% | $577.7M 30.7% | $522.3M 29.6% | $541.8M 32.4% | $497.8M 33.2% | $542.5M 35.3% | $584.2M 36.5% | $567.8M 37.5% | $556.5M 37.6% |
| Research & Development | $16.7M 1.1% | $16.0M 0.9% | $15.6M 0.8% | $15.5M 0.9% | $13.2M 0.8% | $13.4M 0.9% | $15.0M 1.0% | $25.0M 1.6% | $20.7M 1.4% | $16.4M 1.1% |
| Selling, General & Admin | $349.3M 23.3% | $346.4M 19.3% | $307.4M 16.3% | $298.3M 16.9% | $285.4M 17.1% | $274.9M 18.3% | $275.5M 17.9% | $272.5M 17.0% | $280.3M 18.5% | $275.9M 18.6% |
| Operating Income | $75.5M 5.0% | -$12.3M -0.7% | $88.1M 4.7% | -$43.9M -2.5% | $42.0M 2.5% | -$64.2M -4.3% | $10.3M 0.7% | $138.6M 8.6% | $121.4M 8.0% | $118.8M 8.0% |
| Interest Expense | $62.9M 4.2% | $50.5M 2.8% | $44.6M 2.4% | $27.7M 1.6% | $28.7M 1.7% | $34.9M 2.3% | $41.0M 2.7% | $37.4M 2.3% | $26.4M 1.7% | $24.3M 1.6% |
| Other Income (Expense), net | $3.7M 0.2% | -$6.8M -0.4% | -$2.6M -0.1% | -$32.6M -1.8% | -$4.1M -0.2% | -$9.2M -0.6% | -$8.9M -0.6% | -$4.7M -0.3% | -$1.2M -0.1% | -$1.3M -0.1% |
| Pretax Income | $16.2M 1.1% | -$69.7M -3.9% | $40.9M 2.2% | -$104.2M -5.9% | $9.2M 0.6% | -$106.3M -7.1% | -$38.1M -2.5% | $98.0M 6.1% | $96.3M 6.4% | $95.2M 6.4% |
| Income Tax Expense | $40.7M 2.7% | -$10.0M -0.6% | $1.8M 0.1% | -$4.4M -0.2% | $6.4M 0.4% | -$18.7M -1.2% | $806K 0.1% | -$9.1M -0.6% | $22.4M 1.5% | $29.1M 2.0% |
| Net Income | -$24.5M -1.6% | -$59.7M -3.3% | $39.3M 2.1% | -$99.8M -5.7% | $2.9M 0.2% | -$87.2M -5.8% | -$38.0M -2.5% | $107.4M 6.7% | $74.4M 4.9% | $66.7M 4.5% |
| Per Share | ||||||||||
| EPS (Basic) | -$0.79 | -$1.93 | $1.28 | -$3.18 | $0.09 | -$2.79 | -$1.21 | $3.39 | $2.31 | $2.04 |
| EPS (Diluted) | -$0.79 | -$1.93 | $1.26 | -$3.18 | $0.09 | -$2.79 | -$1.21 | $3.37 | $2.28 | $2.03 |
| Weighted Avg Shares (Basic) | 31.1M | 30.9M | 30.8M | 31.4M | 31.7M | 31.2M | 31.4M | 31.7M | 32.2M | 32.6M |
| Weighted Avg Shares (Diluted) | 31.1M | 30.9M | 31.3M | 31.4M | 32.0M | 31.2M | 31.4M | 31.9M | 32.6M | 32.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 19th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE -5% against ROIC -2% — -3% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 42.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 63.5 | 64.7 | 66.8 | 67.6 | 70.4 | 69.3 | 70.5 | 66.1 |
| Gross Profit | 36.5 | 35.3 | 33.2 | 32.4 | 29.6 | 30.7 | 29.5 | 33.9 |
| R&D | 1.6 | 1.0 | 0.9 | 0.8 | 0.9 | 0.8 | 0.9 | 1.1 |
| SG&A | 17.0 | 17.9 | 18.3 | 17.1 | 16.9 | 16.3 | 19.3 | 23.3 |
| Operating Income | 8.6 | 0.7 | -4.3 | 2.5 | -2.5 | 4.7 | -0.7 | 5.0 |
| Income Tax | -0.6 | 0.1 | -1.2 | 0.4 | -0.2 | 0.1 | -0.6 | 2.7 |
| Net Income | 6.7 | -2.5 | -5.8 | 0.2 | -5.7 | 2.1 | -3.3 | -1.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MATW: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $32.4M covers the $0 due within a year 32433000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-09-30 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~8.8% on $710.8M of debt.
Cash of $32.4M fully covers short-term debt of $7.2M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Earns -5.55pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 0.4% | 10.0% (today's — no rate published for this year) | -9.6pts |
| FY2020 | -3.0% | 10.0% (today's — no rate published for this year) | -13.0pts |
| FY2021 | 2.0% | 7.5% | -5.5pts |
| FY2022 | -2.3% | 8.9% | -11.2pts |
| FY2023 | 4.4% | 8.2% | -3.8pts |
| FY2024 | -0.7% | 9.0% | -9.7pts |
| FY2025 | 4.2% | 9.4% | -5.3pts |
| Now | -2.1% | 10.0% | -12.1pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 37.6% | 8.0% | 4.5% |
| FY2017 | 37.5% | 8.0% | 4.9% |
| FY2018 | 36.5% | 8.6% | 6.7% |
| FY2019 | 35.3% | 0.7% | -2.5% |
| FY2020 | 33.2% | -4.3% | -5.8% |
| FY2021 | 32.4% | 2.5% | 0.2% |
| FY2022 | 29.6% | -2.5% | -5.7% |
| FY2023 | 30.7% | 4.7% | 2.1% |
| FY2024 | 29.5% | -0.7% | -3.3% |
| FY2025 | 33.9% | 5.0% | -1.6% |
Return on equity is 3 points BELOW the return on invested capital, which means the equity base is carrying capital the operations are not earning on — usually cash, goodwill, or a recent raise.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$439M of goodwill — 37% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
ROIC ex-goodwill is 7.11% against 4.47% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Missing from our data, so excluded from this answer: 3 years of cash flow.
Stressed coverage falls to 0.8x — below the level at which interest is reliably covered.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 1.20x |
| 5% | 1.14x |
| 10% | 1.08x |
| 15% | 1.02x |
| 20% | 0.96x |
| 25% | 0.90x |
| 30% | 0.84x |
| 35% | 0.78x |
| 40% | 0.72x |
| 45% | 0.66x |
| 50% | 0.60x |
| 55% | 0.54x |
| 60% | 0.48x |
Ladder as of 2025-09-30 (10-K); cash from the 2025-09-30 balance sheet; FCF from FY2025. Free cash flow is negative, so projected resources fall rather than accumulate.
Balance sheet at 2025-09-30. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Free cash flow is negative, so debt service depends on the cash balance rather than on the business.
At $19.34, free cash flow must compound 18.21%/yr for 10 years. It has no positive compounding record to compare against.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 55.9% | 18.2% |
| FY2021 | −11.7% | 18.2% |
| FY2022 | −49.0% | 18.2% |
| FY2023 | −55.9% | 18.2% |
| FY2024 | 17.8% | 18.2% |
| FY2025 | −274.3% | 18.2% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 1 of the last 6 years.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Nauman J Michael Director | Open-market buy | 1,000 | $19.99 | $20k |
| 2026-08-31 | Whitehead Michael J President and CEO | Grant | 69,198 | $0.00 | — |
| 2026-08-24 | Nauman J Michael Director | Open-market buy | 1,000 | $21.08 | $21k |
| 2026-08-20 | Nauman J Michael Director | Open-market buy |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 1,900 |
| $21.96 |
| $42k |
| 2026-08-19 | Nauman J Michael Director | Open-market buy | 100 | $21.98 | $2k |
| 2026-08-14 | Richards Aleta W. Director | Open-market buy | 3,000 | $23.06 | $69k |
| 2026-08-10 | Nauman J Michael Director | Open-market buy | 2,000 | $22.97 | $46k |
| 2026-08-10 | Schawk David A Director | Open-market buyindirect | 5,000 | $23.60 | $118k |
| 2026-06-01 | Schawk David A Director | Giftindirect | 198,014 | $0.00 | $0 |
| 2026-05-14 | 2 co-filers Group filing | Option exercise | 3,989 | $0.00 | $0 |
| 2026-05-14 | 2 co-filers Group filing | Option exercise | 3,989 | $0.00 | — |
| 2026-03-19 | 2 co-filers Group filing | Gift | 4,668 | $0.00 | $0 |
| 2026-03-19 | 2 co-filers Group filing | Giftindirect | 4,668 | $0.00 | $0 |
| 2026-03-12 | Etzkorn Lillian Director | Grant | 5,556 | $0.00 | — |
| 2026-03-12 | Schawk David A Director | Grant | 5,556 | $0.00 | — |
| 2026-03-12 | Wlodarczyk Francis Director | Grant | 5,556 | $0.00 | — |
| 2026-03-12 | Dunlap Terry L Director | Grant | 5,556 | $0.00 | — |
| 2026-03-12 | Dietze Katherine Elizabeth Director | Grant | 5,556 | $0.00 | — |
| 2026-03-12 | Richards Aleta W. Director | Grant | 5,556 | $0.00 | — |
| 2026-03-12 | Obrien Morgan K Director | Grant | 5,556 | $0.00 | — |
| 2026-03-12 | Nauman J Michael Director | Grant | 5,556 | $0.00 | — |
| 2026-03-12 | Gebhardt Thomas Director | Grant | 5,556 | $0.00 | — |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | $0 |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | $0 |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | $0 |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | $0 |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | $0 |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | $0 |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | — |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | — |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | — |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | — |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | — |
| 2026-03-07 | 2 co-filers Group filing | Option exercise | 4,668 | $0.00 | — |
| 2025-12-19 | Lane Lee EVP (Group Pres Ind and Envir) | Grant | 22,470 | $0.00 | — |
| 2025-12-15 | Garcia Tunon Alvaro Director | Grant | 400 | $0.00 | — |
| 2025-11-20 | 3 co-filers CFO and Treasurer | Option exercise | 22,800 | $0.00 | $0 |
| 2025-11-20 | 3 co-filers President and CEO | Option exercise | 90,000 | $0.00 | $0 |
| 2025-11-20 | 3 co-filers Chief Information Officer | Option exercise | 3,600 | $0.00 | $0 |
| 2025-11-20 | 3 co-filers EVP, Group Pres, Memorial | Option exercise | 13,800 | $0.00 | $0 |